CMPS Company Profile and Key Details

CMPS has shown sold momentum, gaining 4.43% over the past week and 12.12% over the past quarter, though year-to-date performance is up 5.94%. Short-term trend indicators are bearishly aligned (SMA20 5.69%, SMA50 5.79%, SMA200 35.28%). The stock’s 14-day RSI is 52.64 (neutral), while the ATR of 0.65 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -17.64% below its high and over 225.78% above its low. Average 10-day trading volume of 2.44 million shares is below the 3-month average of 2.74 million, indicating normal recent market interest.

COMPASS Pathways plc has 95.94 million shares outstanding. The public float is 58.41 million shares, elevated short interest at 8.26% of float. This equals 7.78 million shares. The short ratio is 4.18 days. Institutional investors hold 64.17% of the float. Insiders own 13.3%. ATAI Life Sciences N.V. holds 6.91 million shares, Malievskaia Ekaterina has 3.15 million shares and Goldsmith George Jay has 3.15 million shares.

COMPASS Pathways plc (NASDAQ:CMPS) closed at $5.88 USD, losing -$0.18 (-2.97%) from the previous close of $6.06. The stock is currently mid-range between its 52-week high and low $2.25 and $8.90. With a market capitalization of about $564.49 million, COMPASS Pathways plc is classified as a small-cap and shows higher-than-market volatility (beta ~1.98). Key stats such as the average daily volume over the past year has been around 2.77 million shares, volume is running light vs its 52-week average. Headquartered in London, None, COMPASS Pathways plc operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Kabir Kumar Nath, the company employs approximately 166 people and listed since September 18, 2020. COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States.

COMPASS Pathways plc last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.97. This means the shares are trading above this model’s fair value.

Wall Street analysts project EPS growth of 9.72% annually over the next five years. The latest quarter delivered EPS of -$1.44. The next quarter is forecast at -$0.40. Next year's EPS is expected at -$2.31. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 6 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $70.00 to $6.00. The high target offers 1090.48% upside. The low target suggests 2.04% downside. The mean target is $25.64. This offers 336.05% upside. COMPASS Pathways plc earnings surprise history is a mixed track record. The quarter that ended November 04, 2025, missed forecasts by 261.13%. The prior quarter beat by 2.7%. Over the last six quarters, Apple has recorded several small beats. These include -99.89% in August 01, 2024.

COMPASS Pathways plc trades at a P/E ratio of -2.38, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 15.03 reflecting a rich premium to book value. The P/FCF stands at -3.53, also below market averages. Compared to sector medians, COMPASS Pathways plc P/S is trading at a discount to the sector, and the P/B is far lower than peers, underscoring the brand and earnings power premium investors assign to the stock.

COMPASS Pathways plc (NASDAQ:CMPS) shares are flat 5.94% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows COMPASS Pathways plc trading at a premium to the broader market with a P/E of -2.38. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $47.75, suggesting 712.07% upside. Our AI forecast model points to short-term strength (8.84% over two weeks), a medium-term rise (71.26% over three months), and a longer-term gain (336.05% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that COMPASS Pathways plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 8.84%, with price expected at $6.40 by March 31, 2026, within a range of $5.61 to $7.15 3-Month Outlook: Projected rise of 71.26%, reaching $10.07 by June 15, 2026, with a range of $9.87 to $10.27. 1-Year Outlook: Projected gain of 336.05%, with price at $25.64 by March 17, 2027, within a range of $21.28 to $34.82.